What is the address of Dr. Ann Colson, nefrologie BV?

The registered office of Dr. Ann Colson, nefrologie BV is located at Struikheidestraat(MZN) 6, 2812 Mechelen.

Is Dr. Ann Colson, nefrologie BV still active?

Yes. According to the CBE (30 September 2026) Dr. Ann Colson, nefrologie BV is active, legal situation “Normale toestand”, started on 23 September 2015.

Is Dr. Ann Colson, nefrologie BV registered on Peppol?

Yes, Dr. Ann Colson, nefrologie BV is registered on the Peppol network with ID 0208:0638772318.

What is the enterprise number of Dr. Ann Colson, nefrologie BV?

The enterprise number of Dr. Ann Colson, nefrologie BV is BE0638772318.

When was Dr. Ann Colson, nefrologie BV founded?

Dr. Ann Colson, nefrologie BV was founded on 23 September 2015.

Who are the directors of Dr. Ann Colson, nefrologie BV?

According to the 2025 annual accounts, the directors of Dr. Ann Colson, nefrologie BV are: Ann COLSON.

Is Dr. Ann Colson, nefrologie BV a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 September 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Ann Colson, nefrologie BV make in 2025?

Dr. Ann Colson, nefrologie BV posted a profit after taxes of € 33,349 in financial year 2025.

What is the revenue of Dr. Ann Colson, nefrologie BV?

As a small company, Dr. Ann Colson, nefrologie BV is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 55,908.

Dr. Ann Colson, nefrologie BV (Private Limited)

Dossier Dr. Ann Colson, nefrologie BV, printed on 30 September 2026 from databakkes.be/en/0638772318/dr-ann-colson-nefrologie-bv. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Ann Colson, nefrologie BV from Mechelen, company number BE0638772318, closed financial year 2025 with a result of € 33,349 after tax. For that financial year Dr. Ann Colson, nefrologie BV recorded a gross margin of € 55,908 and equity of € 274,599. Compared with financial year 2024, the result moved from € 172,096 to € 33,349. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.

What it is worth Healthy

€ 274,599

▼ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 33,349

▼ 81% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 258,213

▲ 2% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 55,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 46,819

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 32,600

▼ 25% vs 2024

€ 11,424 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 839

▲ 16% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 9,327

▼ 82% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 283,923 Gross margin 2022: € 283,923 First fiscal year in the series	€ 140,574 Gross margin 2023: € 140,574 ▼ 50% vs 2022 (€ 283,923) Unfavourable step	€ 270,443 Gross margin 2024: € 270,443 ▲ 92% vs 2023 (€ 140,574) Favourable step	€ 55,908 Gross margin 2025: € 55,908 ▼ 79% vs 2024 (€ 270,443) Unfavourable step	▼ 79%
Profit after taxes	€ 209,351 Profit after taxes 2022: € 209,351 First fiscal year in the series	€ 95,307 Profit after taxes 2023: € 95,307 ▼ 54% vs 2022 (€ 209,351) Unfavourable step	€ 172,096 Profit after taxes 2024: € 172,096 ▲ 81% vs 2023 (€ 95,307) Favourable step	€ 33,349 Profit after taxes 2025: € 33,349 ▼ 81% vs 2024 (€ 172,096) Unfavourable step	▼ 81%
Equity	€ 418,846 Equity 2022: € 418,846 First fiscal year in the series	€ 464,154 Equity 2023: € 464,154 ▲ 11% vs 2022 (€ 418,846) Favourable step	€ 296,250 Equity 2024: € 296,250 ▼ 36% vs 2023 (€ 464,154) Unfavourable step	€ 274,599 Equity 2025: € 274,599 ▼ 7% vs 2024 (€ 296,250) Unfavourable step	▼ 7%
Total debts	€ 195,663 Total debts 2022: € 195,663 First fiscal year in the series	€ 216,029 Total debts 2023: € 216,029 ▲ 10% vs 2022 (€ 195,663) Unfavourable step	€ 423,276 Total debts 2024: € 423,276 ▲ 96% vs 2023 (€ 216,029) Unfavourable step	€ 156,188 Total debts 2025: € 156,188 ▼ 63% vs 2024 (€ 423,276) Favourable step	▼ 63%
Cash	€ 439,568 Cash 2022: € 439,568 First fiscal year in the series	€ 296,502 Cash 2023: € 296,502 ▼ 33% vs 2022 (€ 439,568) Unfavourable step	€ 253,781 Cash 2024: € 253,781 ▼ 14% vs 2023 (€ 296,502) Unfavourable step	€ 258,213 Cash 2025: € 258,213 ▲ 2% vs 2024 (€ 253,781) Favourable step	▲ 2%
Retained profit	€ 400,296 Retained profit 2022: € 400,296 First fiscal year in the series	€ 445,604 Retained profit 2023: € 445,604 ▲ 11% vs 2022 (€ 400,296) Favourable step	€ 277,700 Retained profit 2024: € 277,700 ▼ 38% vs 2023 (€ 445,604) Unfavourable step	€ 256,049 Retained profit 2025: € 256,049 ▼ 8% vs 2024 (€ 277,700) Unfavourable step	▼ 8%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 50,000 Dividend 2023: € 50,000 Unchanged (€ 0) Unchanged	€ 340,000 Dividend 2024: € 340,000 ▲ € 290,000 vs 2023 (€ 50,000) Unchanged	€ 55,000 Dividend 2025: € 55,000 ▼ 84% vs 2024 (€ 340,000) Unchanged	▼ 84%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 54,068 Bank debt 2023: € 54,068 Unchanged (€ 0) Unfavourable step	€ 43,558 Bank debt 2024: € 43,558 ▼ 19% vs 2023 (€ 54,068) Favourable step	€ 32,600 Bank debt 2025: € 32,600 ▼ 25% vs 2024 (€ 43,558) Favourable step	▼ 25%
Balance sheet total	€ 614,509 Balance sheet total 2022: € 614,509 First fiscal year in the series	€ 680,183 Balance sheet total 2023: € 680,183 ▲ 11% vs 2022 (€ 614,509) Unchanged	€ 719,526 Balance sheet total 2024: € 719,526 ▲ 6% vs 2023 (€ 680,183) Unchanged	€ 430,787 Balance sheet total 2025: € 430,787 ▼ 40% vs 2024 (€ 719,526) Unchanged	▼ 40%

Key figures of Dr. Ann Colson, nefrologie BV, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Ann Colson, nefrologie BV?

What happened at Dr. Ann Colson, nefrologie BV in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 15, 2026 New annual accounts for financial year 2025: profit of € 33,349 (▼ 81% vs 2024). Source: NBB ↗
Sep 23, 2015 New establishment in Mechelen. KBO
Sep 23, 2015 Start of the company according to the CBE. KBO

In short

From € 209,351 profit in 2022 to € 33,349 profit in 2025.

Paid € 180,837 in corporate taxes since 2022.

Best year ever: 2022, with € 209,351 profit.

Paid out € 445,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Ann Colson, nefrologie BV? We notify you, reason included.

Follow Dr. Ann Colson, nefrologie BV

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Ann COLSON

Dr. Ann Colson, nefrologie BV

Behind Dr. Ann Colson, nefrologie BV is Ann COLSON.

See the full network in the app

Directors

According to the 2025 annual accounts

Ann COLSON

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Struikheidestraat(MZN) 6

2812 Mechelen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0638.772.318
VAT number: BE 0638.772.318
Registered office: Struikheidestraat(MZN) 6, 2812 Mechelen
Names & denominations: Dr. Ann Colson, nefrologie BV
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 23 September 2015
Peppol: Active · Active since 1 Jan 2001

View on CBE Public ↗ Annual accounts (NBB) ↗